Rune Sundset

Tromso, 9037, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Title Not Found

Title Not Found

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: June 04, 2026

CXCR4-targeted PET imaging of glioblastoma using [68Ga]Ga-TD-01: from pharmacokinetics and dosimetry to theranostic potential.

CXCR4-targeted PET imaging of glioblastoma using [68Ga]Ga-TD-01: from pharmacokinetics and dosimetry to theranostic potential.

Journal: EJNMMI radiopharmacy and chemistry

Published: March 02, 2026

Acoustic cluster therapy mediated enhancement of [68Ga]Ga-PSMA-617 in a murine glioblastoma multiforme model verified by simultaneous PET/MRI.

Acoustic cluster therapy mediated enhancement of [68Ga]Ga-PSMA-617 in a murine glioblastoma multiforme model verified by simultaneous PET/MRI.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 21, 2026

A robust and versatile deep learning model for prediction of the arterial input function in dynamic small animal [18F] FDG PET imaging.

A robust and versatile deep learning model for prediction of the arterial input function in dynamic small animal [18F] FDG PET imaging.

Journal: EJNMMI research

Published: November 05, 2025

Rapid 64Cu radiolabeling and in vivo evaluation of DSPE-NODAGA liposomes in a murine mammary tumor model.

Rapid 64Cu radiolabeling and in vivo evaluation of DSPE-NODAGA liposomes in a murine mammary tumor model.

Journal: Pharmacological research

Published: September 14, 2025

Variability of the arterial input function in small-animal dynamic PET imaging.

Variability of the arterial input function in small-animal dynamic PET imaging.

Journal: EJNMMI research

Published: September 03, 2025

Predictive tumor dosimetry and pharmacokinetic evaluation of [67Cu]Cu-rhPSMA-10.1 and [68Ga]Ga-rhPSMA-10.1 with PET/SPECT MRI in an orthotopic mouse model of glioblastoma.

Predictive tumor dosimetry and pharmacokinetic evaluation of [67Cu]Cu-rhPSMA-10.1 and [68Ga]Ga-rhPSMA-10.1 with PET/SPECT MRI in an orthotopic mouse model of glioblastoma.

Journal: Nuclear medicine and biology

Published: May 05, 2025

¹⁷⁷Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.

¹⁷⁷Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: August 21, 2024

All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful.

All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful.

Journal: EJNMMI research

Published: August 21, 2024

Production of 67Cu at a biomedical cyclotron via 70Zn(p,α)67Cu reaction and its evaluation in a preclinical study using small animal SPECT/CT.

Production of 67Cu at a biomedical cyclotron via 70Zn(p,α)67Cu reaction and its evaluation in a preclinical study using small animal SPECT/CT.

Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine

Published: June 28, 2024

Radiosynthesis and preclinical evaluation of a 68Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma.

Radiosynthesis and preclinical evaluation of a 68Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma.

Journal: EJNMMI radiopharmacy and chemistry

Published: June 07, 2024

Liposomal Nω-hydroxy-l-norarginine, a proof-of-concept: Arginase inhibitors can be incorporated in liposomes while retaining their therapeutic activity ex vivo.

Liposomal Nω-hydroxy-l-norarginine, a proof-of-concept: Arginase inhibitors can be incorporated in liposomes while retaining their therapeutic activity ex vivo.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: June 07, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026